Goblet cell carcinoid of the appendix - Diagnostic challenges and treatment updates: A case report and review of the literature

被引：19
作者：
Gilmore G. [1 ]
Jensen K. [2 ]
Saligram S. [1 ]
Sachdev T.P. [1 ]
Arekapudi S.R. [1 ]
机构：
[1] Department of Medicine, Veterans Affairs Central California Health Care System, University of California San Francisco, 2615 E Clinton Ave, Fresno, 93703, CA
[2] Department of Pathology, Veterans Affairs Palo Alto Health Care System, Stanford Hospital and Clinics, Palo Alto, 94304, CA
来源：
Journal of Medical Case Reports | / 12卷 / 1期
关键词：
Appendix; Chemotherapy; Goblet cell carcinoid;
D O I：
10.1186/s13256-018-1789-6
中图分类号：
学科分类号：
摘要：
Background: Goblet cell carcinoid is a rare but distinct entity of appendiceal tumors which is a hybrid or mixed tumor consisting of both epithelial (glandular) and neuroendocrine elements containing goblet cells. This entity is important to recognize and appropriately grade as it tends to be more aggressive than typical carcinoid tumors, often presenting with metastatic disease. As a result, the 5-year overall survival is 14-22% in stage III-IV disease. GCC therefore warrants more aggressive surgical and medical (chemotherapy) interventions than typical carcinoid tumors. Through this case report we give a brief update on GCC pathological features, staging, surgical management, and review the literature as a guide to indications for chemotherapy and choice of agents. Case presentation: We present the case of a 77-year-old Caucasian man with a history of stage I adenocarcinoma of transverse colon status post transverse colectomy who was incidentally found on surveillance colonoscopy to have an abnormal appendiceal orifice lesion. A biopsy revealed an appendiceal goblet cell carcinoid and he underwent a right hemicolectomy which revealed a pathologic stage III GCC for which he received eight cycles of adjuvant chemotherapy with capecitabine. Conclusions: It is essential that patients who have tumors > 2 cm, are pT3 or pT4, have higher grade histology with signet ring (Tang grade B or grade C), locally advanced, or with positive surgical margins on appendectomy undergo a right hemicolectomy. Although there is no category 1 evidence, consensus recommendations are that patients with stage II (particularly Tang B and C) and stage III GCC be offered adjuvant chemotherapy with a regimen based on 5-fluorouracil, as these patients are known to have high rates of relapse. © 2018 The Author(s).
引用
收藏
相关论文
共 25 条
  • [1] McCusker M.E., Cote T.R., Clegg L.X., Sobin L.H., Primary malignant neoplasms of the appendix: A population-based study from the surveillance, epidemiology and end-results program, 1973-1998, Cancer, 94, 12, pp. 3307-3312, (2002)
  • [2] Turaga K.K., Pappas S.G., Gamblin T.C., Importance of histologic subtype in the staging of appendiceal tumors, Ann Surg Oncol, 19, 5, pp. 1379-1385, (2012)
  • [3] McGory M.L., Maggard M.A., Kang H., O'Connell J.B., Ko C.Y., Malignancies of the appendix: Beyond case series reports, Dis Colon Rectum, 48, 12, pp. 2264-2271, (2005)
  • [4] Pape U., Perren A., Niederle B., Gross D., Gress T., Costa F., Arnold R., Denecke T., Plockinger U., Salazar R., Grossman A., ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinoid, Neuroendocrinology, 95, 2, pp. 135-156, (2012)
  • [5] Pahlavan P.S., Kanthan R., Goblet cell carcinoid of the appendix, World J Surg Oncol, 3, (2005)
  • [6] Jiang Y., Long H., Wang W., Liu H., Tang Y., Zhang X., Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix, Pathol Oncol Res, 17, 1, pp. 127-132, (2011)
  • [7] Park K., Blessing K., Kerr K., Chetty U., Gilmour H., Goblet cell carcinoid of the appendix, Gut, 31, 3, pp. 322-324, (1990)
  • [8] Shenoy S., Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies, World J Gastrointest Surg, 8, 10, pp. 660-669, (2016)
  • [9] Kelly K.J., Management of Appendix Cancer, Clin Colon Rectal Surg, 28, 4, pp. 247-255, (2015)
  • [10] Lamarca A., Nonaka D., Lopez Escola C., Hubner R.A., O'Dwyer S., Chakrabarty B., Fulford P., Valle J.W., Appendiceal Goblet Cell Carcinoids: Management Considerations from a Reference Peritoneal Tumor Service Centre and ENETS Centre of Excellence, Neuroendocrinology, 103, 5, pp. 500-517, (2016)
123